BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Graham NSN, Zimmerman KA, Moro F, Heslegrave A, Maillard SA, Bernini A, Miroz JP, Donat CK, Lopez MY, Bourke N, Jolly AE, Mallas EJ, Soreq E, Wilson MH, Fatania G, Roi D, Patel MC, Garbero E, Nattino G, Baciu C, Fainardi E, Chieregato A, Gradisek P, Magnoni S, Oddo M, Zetterberg H, Bertolini G, Sharp DJ. Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Sci Transl Med 2021;13:eabg9922. [PMID: 34586833 DOI: 10.1126/scitranslmed.abg9922] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Shin SS, Chawla S, Jang DH, Mazandi VM, Weeks MK, Kilbaugh TJ. Imaging of White Matter Injury Correlates with Plasma and Tissue Biomarkers in Pediatric Porcine Model of Traumatic Brain Injury. J Neurotrauma 2023;40:74-85. [PMID: 35876453 DOI: 10.1089/neu.2022.0178] [Reference Citation Analysis]
2 Moro F, Lisi I, Tolomeo D, Vegliante G, Pascente R, Mazzone E, Hussain R, Micotti E, Dieter Dallmeier J, Pischiutta F, Bianchi E, Chiesa R, Wang KKW, Zanier ER. Acute blood levels of neurofilament light indicate one-year white matter pathology and functional impairment in repetitive mild traumatic brain injured mice. J Neurotrauma 2022. [PMID: 36576018 DOI: 10.1089/neu.2022.0252] [Reference Citation Analysis]
3 Fundaun J, Kolski M, Molina-Álvarez M, Baskozos G, Schmid AB. Types and Concentrations of Blood-Based Biomarkers in Adults With Peripheral Neuropathies: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e2248593. [PMID: 36574244 DOI: 10.1001/jamanetworkopen.2022.48593] [Reference Citation Analysis]
4 Liu Y, Yao X, Lv X, Qian J. The role of spectrin breakdown products in patients with traumatic brain injury: a systematic review and meta-analysis. Neurol Sci 2022. [DOI: 10.1007/s10072-022-06558-y] [Reference Citation Analysis]
5 Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier ER. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 2022;13:1070379. [PMID: 36591311 DOI: 10.3389/fimmu.2022.1070379] [Reference Citation Analysis]
6 Kumar S. Neurosurgery in India: Perspective of a Veteran Neurosurgeon. Indian Journal of Neurosurgery 2022;11:193-194. [DOI: 10.1055/s-0042-1760341] [Reference Citation Analysis]
7 Zhan X, Oeur A, Liu Y, Zeineh MM, Grant GA, Margulies SS, Camarillo DB. Translational models of mild traumatic brain injury tissue biomechanics. Current Opinion in Biomedical Engineering 2022;24:100422. [DOI: 10.1016/j.cobme.2022.100422] [Reference Citation Analysis]
8 Niziolek G, Sandsmark DK, Pascual JL. Neurotrauma. Curr Opin Crit Care 2022;28:715-24. [PMID: 36302199 DOI: 10.1097/MCC.0000000000001005] [Reference Citation Analysis]
9 Filley CM. White matter dementia then… and now. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1043583] [Reference Citation Analysis]
10 Delaby C, Bousiges O, Bouvier D, Fillée C, Fourier A, Mondésert E, Nezry N, Omar S, Quadrio I, Rucheton B, Schraen-maschke S, van Pesch V, Vicca S, Lehmann S, Bedel A. Neurofilaments contribution in clinic: state of the art. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1034684] [Reference Citation Analysis]
11 Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier E. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.. [DOI: 10.1101/2022.09.26.22280358] [Reference Citation Analysis]
12 Maas AIR, Menon DK, Manley GT, Abrams M, Åkerlund C, Andelic N, Aries M, Bashford T, Bell MJ, Bodien YG, Brett BL, Büki A, Chesnut RM, Citerio G, Clark D, Clasby B, Cooper DJ, Czeiter E, Czosnyka M, Dams-o'connor K, De Keyser V, Diaz-arrastia R, Ercole A, van Essen TA, Falvey É, Ferguson AR, Figaji A, Fitzgerald M, Foreman B, Gantner D, Gao G, Giacino J, Gravesteijn B, Guiza F, Gupta D, Gurnell M, Haagsma JA, Hammond FM, Hawryluk G, Hutchinson P, van der Jagt M, Jain S, Jain S, Jiang J, Kent H, Kolias A, Kompanje EJO, Lecky F, Lingsma HF, Maegele M, Majdan M, Markowitz A, Mccrea M, Meyfroidt G, Mikolić A, Mondello S, Mukherjee P, Nelson D, Nelson LD, Newcombe V, Okonkwo D, Orešič M, Peul W, Pisică D, Polinder S, Ponsford J, Puybasset L, Raj R, Robba C, Røe C, Rosand J, Schueler P, Sharp DJ, Smielewski P, Stein MB, von Steinbüchel N, Stewart W, Steyerberg EW, Stocchetti N, Temkin N, Tenovuo O, Theadom A, Thomas I, Espin AT, Turgeon AF, Unterberg A, Van Praag D, van Veen E, Verheyden J, Vyvere TV, Wang KKW, Wiegers EJA, Williams WH, Wilson L, Wisniewski SR, Younsi A, Yue J, Yuh EL, Zeiler FA, Zeldovich M, Zemek R. Traumatic brain injury: progress and challenges in prevention, clinical care, and research. The Lancet Neurology 2022. [DOI: 10.1016/s1474-4422(22)00309-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mcdonald SJ, O’brien TJ, Shultz SR. Biomarkers add value to traumatic brain injury prognosis. The Lancet Neurology 2022;21:761-3. [DOI: 10.1016/s1474-4422(22)00306-4] [Reference Citation Analysis]
14 Helmrich IRAR, Czeiter E, Amrein K, Büki A, Lingsma HF, Menon DK, Mondello S, Steyerberg EW, von Steinbüchel N, Wang KKW, Wilson L, Xu H, Yang Z, van Klaveren D, Maas AIR. Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study. The Lancet Neurology 2022;21:792-802. [DOI: 10.1016/s1474-4422(22)00218-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Bagnato S, D’ippolito ME, Boccagni C, De Tanti A, Lucca LF, Pingue V, Colombo V, Rubino F, Andriolo M. Six-month outcomes in patients with hemorrhagic and non-hemorrhagic traumatic disorders of consciousness. Neurol Sci 2022. [DOI: 10.1007/s10072-022-06335-x] [Reference Citation Analysis]
16 Mak G, Menon S, Lu JQ. Neurofilaments in neurologic disorders and beyond. J Neurol Sci 2022;441:120380. [PMID: 36027641 DOI: 10.1016/j.jns.2022.120380] [Reference Citation Analysis]
17 Sjölin K, Aulin J, Wallentin L, Eriksson N, Held C, Kultima K, Oldgren J, Burman J. Serum Neurofilament Light Chain in Patients With Atrial Fibrillation. JAHA. [DOI: 10.1161/jaha.122.025910] [Reference Citation Analysis]
18 Ooi SZY, Spencer RJ, Hodgson M, Mehta S, Phillips NL, Preest G, Manivannan S, Wise MP, Galea J, Zaben M. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review. Neurosurg Rev 2022. [PMID: 35790656 DOI: 10.1007/s10143-022-01827-y] [Reference Citation Analysis]
19 Sjölin K, Kultima K, Larsson A, Freyhult E, Zjukovskaja C, Alkass K, Burman J. Distribution of five clinically important neuroglial proteins in the human brain. Mol Brain 2022;15:52. [PMID: 35765081 DOI: 10.1186/s13041-022-00935-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Graham NSN. Progress towards predicting neurodegeneration and dementia after traumatic brain injury. Brain 2022. [DOI: 10.1093/brain/awac179] [Reference Citation Analysis]
21 Meyfroidt G, Bouzat P, Casaer MP, Chesnut R, Hamada SR, Helbok R, Hutchinson P, Maas AIR, Manley G, Menon DK, Newcombe VFJ, Oddo M, Robba C, Shutter L, Smith M, Steyerberg EW, Stocchetti N, Taccone FS, Wilson L, Zanier ER, Citerio G. Management of moderate to severe traumatic brain injury: an update for the intensivist. Intensive Care Med 2022;48:649-66. [PMID: 35595999 DOI: 10.1007/s00134-022-06702-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
22 Abdulla E, Ahmed N, Al-Salihi MM, Rahman R, E Ferdousse SN, Rahman S, Rahman MM. Letter: Blood Biomarkers and Structural Imaging Correlations Post-Traumatic Brain Injury: A Systematic Review. Neurosurgery 2022. [PMID: 35482296 DOI: 10.1227/neu.0000000000002010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Posti JP, Tenovuo O. Blood-based biomarkers and traumatic brain injury-A clinical perspective. Acta Neurol Scand 2022. [PMID: 35383879 DOI: 10.1111/ane.13620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kammeyer R, Mizenko C, Sillau S, Richie A, Owens G, Nair KV, Alvarez E, Vollmer TL, Bennett JL, Piquet AL. Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders. Front Neurol 2022;13:689975. [DOI: 10.3389/fneur.2022.689975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Thelin EP, Lindblad C. Cerebrospinal Fluid as a Platform for Biomarker Identification in Traumatic Brain Injury. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_78-1] [Reference Citation Analysis]
26 Zheng P, Wang X, Chen J, Wang X, Shi SX, Shi K. Plasma Neurofilament Light Chain Predicts Mortality and Long-Term Neurological Outcomes in Patients with Intracerebral Hemorrhage. Aging and disease 2022. [DOI: 10.14336/ad.2022.21020] [Reference Citation Analysis]
27 Ponsford J, Spitz G, Hicks AJ. Highlights in traumatic brain injury research in 2021. Lancet Neurol 2022;21:5-6. [PMID: 34942137 DOI: 10.1016/S1474-4422(21)00424-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]